Rani Therapeutics Holdings Inc expected to post a loss of 35 cents a share - Earnings Preview

Rani Therapeutics Holdings

20/03/2023 20:28

* Rani Therapeutics Holdings Inc  RANI.OQ   RANI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
March 22. 
    * The San Jose California-based  company is expected to
report
revenue of $108.33 thousand, according to the mean estimate from
6 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Rani Therapeutics
Holdings Inc is for a loss of 35 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Rani
Therapeutics
Holdings Inc is $23​, above​ its last closing price of $6.32.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.46       -0.47      -0.33     Beat    29.5
 Jun. 30 2022  -0.52       -0.58      -0.31     Beat    46.3
 Mar. 31 2022  -0.58       -0.66      -0.29     Beat    56.1​
 Dec. 31 2021  -0.65       -0.49      -0.27     Beat    45.5
 ​​Sep.        -0.18       -0.18      -0.12     Beat    33.3
 30 2021                                                
 Jun. 30 2021  -0.18       -0.18      -0.12     Beat    31.8​
 This summary was machine generated March 20 at 20:27 GMT.  All
figures in US dollars  unless otherwise stated